If Onzetra continues to tank and Nuedexta doesn't meet goals, at what point does Otsuka pull the plug? Between the DOJ investigation and product performance I can't imagine the future is bright even with the pipeline. Thoughts?
Well, Nuedexta does make $300 million with a pretty small sales force, doubt they would just let that disappear. And "possibly" additional indications for Nuedexta would boost sales even more. Now, Onzetra on the other hand they may let that go.
Stop threatening Otsuka bought Avanir because of Nuedexta with a single narrow indication If they push for more, then DOJ here I come
Nuedexta is not going to hit $250m this year. And the DOJ is going take most of that due to our history of off-label promotions. Avanir will not exist in 12 months.
How much more can we do? Is everybody on a pip out there? I also tired of being berated for not growing enough. My mgr is a weirdo.
Most of my region are on s PIP Maybe that's why the DOJ is Investigating this horrible company How much PBA is there to warrant The amount of business that Avanir is Pushing for
90 reps out of 220 had less than 20 Onzetra scripts for Q1. How long will Otsuka put up with this ? The pressure from managers especially in the Midwest is super intense. Increase sales or else. I guess that's why over half of the sales force has turned over.
This is true. Avanir will not exist within 12 months of the DOJ final decision. The LTC sales force will become Otsuka's LTC sales force and most support functions will be gone.